Mocumbi Ana Olga H, Yacoub Magdi H, Yokohama Hideky, Ferreira Maria Beatriz
Imperial College, NHLI SW7 2AZ, London, United Kingdom.
Cardiovasc Pathol. 2009 Jan-Feb;18(1):64-5. doi: 10.1016/j.carpath.2007.12.009. Epub 2008 Mar 4.
Endomyocardial fibrosis (EMF) is a neglected tropical cardiomyopathy of unknown etiology and pathogenesis that is common in certain tropical areas of Africa, Asia, and South America. It affects predominantly children and young adults. Endocardial fibrosis is the hallmark of this restrictive cardiomyopathy leading to restriction to diastolic filling of the ventricles with severe atrial dilatation. Endomyocardial fibrosis carries a poor prognosis, due to the late presentation of patients. The salient features of this condition are present in the case presented here of a 14-year-old boy who died from progressive heart failure due to right ventricular EMF. These pathological findings of advanced disease highlight the need for early diagnosis and better understanding of the pathogenesis in order to improve prognosis of this debilitating and fatal disease.
心内膜心肌纤维化(EMF)是一种病因和发病机制不明的被忽视的热带心肌病,在非洲、亚洲和南美洲的某些热带地区较为常见。它主要影响儿童和年轻人。心内膜纤维化是这种限制性心肌病的标志,导致心室舒张期充盈受限并伴有严重的心房扩张。由于患者就诊较晚,心内膜心肌纤维化的预后较差。本文介绍的一名14岁男孩因右心室EMF导致进行性心力衰竭死亡,该病例体现了这种疾病的显著特征。这些晚期疾病的病理发现凸显了早期诊断和更好地了解发病机制的必要性,以便改善这种使人衰弱且致命疾病的预后。